Last reviewed · How we verify

Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis (MUCOLAX)

NCT04458129 PHASE2 UNKNOWN

The main objective of the study is to evaluate the effectiveness of polyethylene glycol treatment on intestinal inflammation in children with cystic fibrosis. In this test, a method adapted from the Fleming one-step scheme will be used. The success rate is measured by the proportion of patients with fecal calprotectin levels \< 250 µg/g at 3 months after treatment initiation.

Details

Lead sponsorUniversity Hospital, Bordeaux
PhasePHASE2
StatusUNKNOWN
Enrolment23
Start dateWed Jul 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Jul 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions